Olea launches contact-less alternative to spirometer
RENO, Nev. – Olea Sensor Networks has launched RespiroTrack with Olea Sense, a development platform with software analytics for contact-less remote health monitoring for patients with conditions like COPD, congestive heart failure and asthma. “This is a major step forward in digital health,” said Frank Morese, Olea CEO/CTO and founder, in a press release. “We believe the time has come for this product, as market leaders seek the most advanced, streamlined, connected technologies to facilitate efficiency and outreach in health care markets worldwide.” The wireless device is able to collect and process respiration data and extract statistics using the company’s sensor analytics and transmit the information to the cloud. No external wires and no contact with the body are required. The device is smaller than an average business card and can be embedded in a bed or worn on the user.
Reliq Health launches remote patient monitoring pilot
VANCOUVER, B.C. – Reliq Health Technologies has begun enrolling patients in the pilot of its remote patient monitoring and care collaboration solution with the National Health Service England. “The goal of this pilot is to demonstrate the value of Reliq Health’s self-care solution in improving health outcomes and reducing the cost of care delivery for chronic disease patients after they are discharged from hospital,” said Dr. Lisa Crossley, CEO of Reliq Health, in a press release. Reliq’s platform uses a combination of secure cloud-based software, voice technology, wearable devices and sensors to support patients and their loved ones in managing their chronic conditions at home. The system provides real-time tracking of patients’ vital signs, medication adherence and movements within the home.
Prostate cancer app helps patients navigate treatment options
MANHASSET, N.Y. – A team of researchers at the Feinstein Institute for Medical Research has developed a mobile app designed to guide patients living with prostate cancer through the treatment decision process. “This tool has the potential to successfully guide patients through their cancer treatment,” said Michael Diefenbach, Ph.D., scientist and Northwell Health director of Behavioral Research in the Department of Medicine and Urology, in a statement. The app uses prompts to lead the patient through the initial decision process to pursue treatment or ongoing observations by a health care professional. If they decide treatment, the app then provides additional questions with statements related to treatment requirements and outcomes. Based on the patient’s answers, the software’s algorithm matches their preferences to a treatment option. Patients can then discuss the treatment approach with their physician and have the option to email the results to the provider. The research team will initiate a randomized controlled trial to further study the app and determine the extent of its usability and helpfulness in a clinical setting.
Researchers connect wearable sensor data to health risk
WILMINGTON, N.C. – Researchers at science and technology growth company Lapetus Solutions have figured out how to translate the step count from wearable sensors into a verifiable measure of health risk.
“Hold onto your Fitbit—the data generated by this and other devices is far more valuable than you might think,” said Dr. S. Jay Olshansky, chief scientist at Lapetus, in a statement.
Lapetus researchers combine age, sex, height and weight, walking speed, stride length, steps per mile and calories burned per step and translate this data into rich information that reflects improvements in health and expected gains in life expectancy and healthy life expectancy if the level of physical activity is continued.
“Consider a 65-year-old male with a height of 5’7” weighing 175 pounds,” explained Olshansky. “By walking at four miles per hour for a short time during most days of the week, he can reduce his risk of death by 33% relative to people who are sedentary.”
Olshansky said the Lapetus science team is also working toward including other wearable data, such as blood pressure, blood sugar and sleep patterns.
“Taken together, health data from wearable sensors provides a more accurate picture of your overall health than the snapshot you get from blood and urine collected on the day of your once-a-year checkup,” said Olshansky.
Dr. Karl Ricanek, CIO and chief data scientist at Lapetus, said that combining data from wearable devices with other sources of data like that collected in a facial image, an individual can develop a scientifically advanced long-term assessment of their own health.
“Combining a selfie with wearable sensors provides unprecedented information about a person’s health and wellness,” said Ricanek in a statement. “The selfie is just another type of sensor that tracks with our age and health.”
When health information from wearable devices and facial analytics is then combined with personal financial information and education, age, gender and family history, Lapetus believes it is possible to create an overall health and financial risk score, called a Better Life and Scoring System (BLISS), which the company plans to launch early next year.
“Data gathering tools, analysis and scoring systems should help investment and health product companies better design, underwrite and implement solutions for consumers, at much lower prices,” said Norvell Miller, president of Lapetus, in a statement.